Cited by 27Bipolar Disorder and TreatmentMaternal Mental Health During Pregnancy and PostpartumMenopause: Health Impacts and Treatments

Progression of female reproductive stages associated with bipolar illness exacerbation

Open access
Marsh, Wendy K, Ketter, Terence A, Crawford, Sybil L, Johnson, Julia V, Kroll‐Desrosiers, Aimee R, Rothschild, Anthony J·2012·Bipolar Disorders

Abstract

Marsh WK, Ketter TA, Crawford SL, Johnson JV, Kroll‐Desrosiers AR, Rothschild AJ. Progression of female reproductive stages associated with bipolar illness exacerbation. Bipolar Disord 2012: 14: 515–526. © 2012 The Authors. Journal compilation © 2012 John Wiley & Sons A/S. Objectives: Late perimenopause and early postmenopause confer an increased risk of depression in the population, yet bipolar disorder mood course during these times remains unclear. Methods: Clinic visits in 519 premenopausal, 116 perimenopausal (including 13 women transitioning from perimenopause to postmenopause), and 133 postmenopausal women with bipolar disorder who received naturalistic treatment in the multisite Systematic Treatment Enhancement Program for Bipolar Disorder (STEP‐BD) study over 19.8 ± 15.5 months were analyzed for mood state. History of postpartum and perimenstrual mood exacerbation and current hormone therapy were evaluated as potential mood predictors. Results: A progression in female reproductive stage (premenopause, perimenopause, and postmenopause) was significantly associated with percent of visits decreasing in euthymia (29.3%, 27.0%, 25.0%, respectively, p < 0.05), decreasing in syndromal mood elevation (5.3%, 4.1%, and 3.0%, respectively, p < 0.001), and increasing in subsyndromal symptoms (47.3%, 50.7%, and 52.7%, respectively, p = 0.05). Thirteen women transitioning from peri‐ to postmenopause had a significantly greater proportion of visits in syndromal depression (24.4%, p < 0.0005) compared to premenopausal, perimenopausal, and postmenopausal women, while depression in the latter three groups (18.1%, 18.1%, and 19.3%, respectively) did not differ. Perimenstrual and/or postpartum mood exacerbation, or hormone therapy did not significantly alter depression during perimenopause. Conclusions: A progression in female reproductive stages was associated with bipolar illness exacerbation. A small number of women transitioning from perimenopause to postmenopause had significantly greater depression than other female reproductive groups. Euthymia and mood elevation decreased with progressing female reproductive stage. Menstrual cycle or postpartum mood exacerbation, or current hormone therapy use, was not associated with perimenopausal depression. Future studies, which include hormonal assessments, are needed to confirm these preliminary findings.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1399-5618.2012.01026.x

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • For many women, stress and hormonal changes associated with the transition to menopause may increase or trigger mood symptoms.

    “For many women, stress and hormonal changes associated with the transition to menopause may increase or trigger mood symptoms.550, 551, 552”

    From Canadian Network for Mood and Anxiety Treatments ( <scp>CANMAT</scp> ) and International Society for Bipolar Disorders ( <scp>ISBD</scp> ) 2018 guidelines for the management of patients with bipolar disorder (2018) · cites this paper as [552]

    The Introduction (page unavailable) describes frequent psychological symptoms during the menopausal transition, an increased risk of depressed mood, and a possible relationship between hormonal fluctuation and mood. The Results (page unavailable) find more visits with depression among women with bipolar disorder transitioning from perimenopause to postmenopause. The paper does not establish stress as a trigger, and its own findings concern women with bipolar disorder rather than women generally. (LLM, conf=0.85)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. [21]Marsh WK Templeton A Ketter TA Rasgon N Clinical Course of Bipolar Disorder Through Perimenopause: Chart Review Annual Meeting American Psychiatric Association Atlanta, GA 2005
  2. [51]Kinkelin M Verlauf und Prognose des Manisch-Depressiven Irreseins Arch Neruol Psyciat 1954 73 100 46 13195578

Cited by

Sorted by citations

Authors
Marsh, W. K., Ketter, T. A., Crawford, S. L., Johnson, J. V., Kroll‐Desrosiers, A. R., & Rothschild, A. J.
Affiliations
  • UMass Memorial Health Care (US)
  • Stanford Medicine (US)
  • University of Massachusetts Chan Medical School (US)
Corresponding author
Marsh, Wendy K
Venue
Bipolar Disorders
Publisher
Wiley
Published
2012-05-31
Volume
14
Issue
5
Pages
515-526
ISSN
  • 1398-5647 (ISSN-L)
  • 1399-5618
OpenAlex
W2160100584
Cited by
27
References
55
Citations by year
2025: 4 · 2022: 2 · 2021: 1 · 2020: 3 · 2019: 4 · 2018: 2 · 2017: 4 · 2016: 1 · 2015: 1 · 2014: 2 · 2013: 3
FWCI
1.37
Type
journal article
Language
en
Open access
Locations
  • Bipolar Disorders (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • eScholarship@UMassChan (submittedVersion)
Funders
  • American Psychiatric Publishing
  • AstraZeneca
  • National Institutes of Health (n01mh80001-12-0-0)
  • National Institute of Mental Health (01MH80001, N01 MH080001)
  • National Center for Research Resources (KL2RR031981)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
Keywords
bipolar disorder, perimenopause, postmenopause, depression, euthymia, mood improvement, subsyndromal symptoms, postpartum mood, hormone therapy, menstrual cycle
MeSH terms
Adult, Affect, Aged, Aged, 80 and over, Aging, Bipolar Disorder, Depressive Disorder, Female, Humans, Longitudinal Studies, Middle Aged, Premenstrual Syndrome, Prospective Studies, Estrogen Replacement Therapy, Premenopause, Postmenopause, Disease Progression, Perimenopause

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review